Skip to main content

Unmet Needs in Patients with Myeloma

Hematologic Cancers, Conference Correspondent, ASH Highlights
Conference Correspondent 
Beth Faiman, PhD, APRN-BC, AOCN
Founding Editor in Chief
Patients with newly diagnosed multiple myeloma have different needs than pateints relapsed/refractory disease, and Beth Faiman addresses what some of these needs are.

Related Items

Polatuzumab Vedotin plus R-CHP Outperforms Standard of Care in Treatment of DLBCL
TOP - March 2022 Vol 15, No 2
ASH Highlights, Lymphoma
Time-Limited Venetoclax-Based Regimens Demonstrate Promising Efficacy in Fit Patients with CLL
TOP - March 2022 Vol 15, No 2
ASH Highlights
Mosunetuzumab Induces Deep Remissions in Patients with Relapsed/Refractory Follicular Lymphoma
By William King
TOP - January 2022 Vol 15, No 1 – Online Only
ASH Highlights
Results from 2 Studies Provide Insights on Antibody Response to COVID-19 Vaccines in Patients with Hematologic Malignancies
By William King
TOP - January 2022 Vol 15, No 1 – Online Only
ASH Highlights